CVS Health Corp (NYSE:CVS)’s traded shares stood at 1.52 million during the latest session, with the company’s beta value hitting 0.53. At the last check today, the stock’s price was $56.90, to imply an increase of 1.39% or $0.78 in intraday trading. The CVS share’s 52-week high remains $83.25, putting it -46.31% down since that peak but still an impressive 7.26% since price per share fell to its 52-week low of $52.77. The company has a valuation of $71.58B, with an average of 15.32 million shares in intraday trading volume over the past 10 days and average of 10.42 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for CVS Health Corp (CVS), translating to a mean rating of 1.93. Of 20 analyst(s) looking at the stock, 0 analyst(s) give CVS a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 14 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 1.56.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CVS Health Corp (NYSE:CVS) trade information
After registering a 1.39% upside in the latest session, CVS Health Corp (CVS) has traded red over the past five days. The 5-day price performance for the stock is -5.70%, and -3.58% over 30 days. With these gigs, the year-to-date price performance is -27.94%. Short interest in CVS Health Corp (NYSE:CVS) saw shorts transact 19.75 million shares and set a 2.27 days time to cover.
The extremes give us $63 and $127 for target low and target high price respectively. As such, CVS has been trading -123.2% off suggested target high and -10.72% from its likely low.
CVS Health Corp (CVS) estimates and forecasts
Looking at statistics comparing CVS Health Corp share performance against respective industry, we note that the company has outperformed competitors. CVS Health Corp (CVS) shares are -15.30% down over the last 6 months, with its year-to-date growth rate higher than industry average at -26.66% against -37.50%. Revenue is forecast to shrink -29.40% this quarter before falling -20.80% for the next one. The rating firms project that company’s revenue will grow 3.30% compared to the previous financial year.
Revenue forecast for the current quarter as set by 17 analysts is 92.75B. Meanwhile, for the current quarter, a total of 17 analyst(s) estimate revenue growth to 96.86B.
CVS Dividends
CVS Health Corp has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. CVS Health Corp has a forward dividend ratio of 2.66, with the share yield ticking at 4.67% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 2.93%.
CVS Health Corp (NYSE:CVS)’s Major holders
CVS Health Corp insiders hold 0.12% of total outstanding shares, with institutional holders owning 83.19% of the shares at 83.29% float percentage. In total, 83.19% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 116.35 million shares (or 9.2341% of shares), all amounting to roughly $6.87 billion.
The next major institution holding the largest number of shares is BLACKROCK INC. with 100.15 million shares, or about 7.9485% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $5.91 billion.
